Cargando…
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869116/ https://www.ncbi.nlm.nih.gov/pubmed/33368829 http://dx.doi.org/10.1002/onco.13657 |
_version_ | 1783648565665464320 |
---|---|
collection | PubMed |
description | For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology. |
format | Online Article Text |
id | pubmed-7869116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78691162021-02-17 ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies Oncologist Conference Perspectives For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology. John Wiley & Sons, Inc. 2020-12-28 2021-02 /pmc/articles/PMC7869116/ /pubmed/33368829 http://dx.doi.org/10.1002/onco.13657 Text en © 2020 AlphaMed Press |
spellingShingle | Conference Perspectives ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies |
title |
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies |
title_full |
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies |
title_fullStr |
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies |
title_full_unstemmed |
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies |
title_short |
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies |
title_sort | ash registry offers insights on covid‐19 in patients with hematologic malignancies |
topic | Conference Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869116/ https://www.ncbi.nlm.nih.gov/pubmed/33368829 http://dx.doi.org/10.1002/onco.13657 |